KraneShares Emerging Market Healthcare Index ETF (KMED)
| Assets | $4.45M |
| NAV | $29.69 |
| Expense Ratio | 0.80% |
| PE Ratio | 31.90 |
| Shares Out | 150,000 |
| Dividend (ttm) | $0.01 |
| Dividend Yield | 0.03% |
| Ex-Dividend Date | Dec 29, 2020 |
| 1-Year Return | - |
| Volume | 209 |
| Open | 29.65 |
| Previous Close | 29.65 |
| Day's Range | 29.35 - 29.57 |
| 52-Week Low | 29.35 |
| 52-Week High | 39.86 |
| Beta | 0.67 |
| Holdings | 150 |
| Inception Date | Aug 29, 2018 |
About KMED
The investment seeks to provide investment results that, before fees and expenses, track the price and yield performance of the Solactive Emerging Markets Healthcare Index (the index). The fund will invest at least 80% of its total assets in components of the index, depositary receipts, representing such components, and securities underlying depositary receipts in the index. The underlying index includes companies that RBICS classifies as engaged in the pharmaceuticals, biotechnology, medical specialties, managed health care, hospital/nursing management, medical/nursing services and services to the health industry businesses. The fund is non-diversified.
Top 10 Holdings
35.72% of assets| Name | Symbol | Weight |
|---|---|---|
| Samsung BioLogics Co Ltd | 207940.KS | 5.03% |
| Sun Pharmaceuticals Industries Ltd | SUNPHARMA.NS | 4.64% |
| Celltrion Inc | 068270.KS | 4.14% |
| Rede d or Sao Luiz SA Ordinary Shares | RDOR3.SA | 4.07% |
| Shenzhen Mindray Bio-Medical Electronics Co Ltd | 300760.SZ | 3.79% |
| WuXi Biologics (Cayman) Inc | 2269.HK | 3.46% |
| Divi's Laboratories Ltd | DIVISLAB.NS | 3.25% |
| Jiangsu Hengrui Pharmaceuticals Co Ltd | 600276.SS | 2.64% |
| IHH Healthcare Bhd | IHH.KL | 2.57% |
| Zhangzhou Pientzehuang Pharmaceutical Co Ltd | 600436.SS | 2.14% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 29, 2020 | $0.0082 | Dec 31, 2020 |
| Dec 27, 2019 | $0.37893 | Dec 31, 2019 |
| Dec 26, 2018 | $0.00301 | Dec 28, 2018 |
News
China Calls for Global Cooperation, Pledges 2 Billion Covid-19 Vaccines
The Chinese government has promised 2 billion vaccines to help developing nations in the face of the highly contagious Covid-19 variant delta, as reported by the Wall Street Journal. President XI Jinpin...
Access the Burgeoning Healthcare Sector Overseas with ‘KMED'
Emerging markets (EM) took their lumps from the Covid-19 pandemic, but as these economies re-emerge, look to strength in the healthcare sector with the KraneShares Emerging Markets Healthcare Index ETF ...
As WHO Approves Second Chinese Covid-19 Vaccine, ‘KMED' Could Benefit
On Tuesday, the World Health Organization approved a Covid-19 vaccine produced by Sinovac Biotech for emergency use, the second vaccine created in China to be approved according to Reuters. That could b...
3 Emerging Markets ETFs For 2021
One of the asset classes generating plenty of buzz as a 2021 idea is emerging markets. Up 4.5% over the past month, the MSCI Emerging Markets Index is already pricing in that enthusiasm.